Our Entrepreneurs

Gabriel Fernández

Laboratorios Clausen

Gabriel Fernández Gabriel Fernández

Impact metric

307% growth in jobs since selection
“I saw an opportunity to advance cancer research in Uruguay.
Country
Uruguay
Industry
Prof. Services
Employees
137
partner
Leonardo Olivera
Website

Company Snapshot

Laboratorios Clausen is the first and only Uruguayan biotech firm to develop an entirely new molecule. Thrombopoetin, a human protein that stimulates the production of platelets, was patented in 1998. Today it is used in treatments for cancer and blood coagulation disorders. To elevate Laboratorios Clausen to the next level, Gabriel and Leonardo have constructed a state-of-the-art production facility that is one of only three EMEA Certified facilities in Latin America. Clausen was the subject of a Universidad ORT Uruguay case study.

Since selection by Endeavor, company revenues have grown by 256%.

Endeavor and Rinquepharma

Gabriel and Leo have benefited from local strategic mentorship, support in strengthening their patent applications, custom workshops on management issues, and introductions to local business leaders to help foster the country’s biotech industry. They also benefited from the Ernst & Young Fellows program, and the eMBA program which developed a business plan for new patents and methods of seeking capital.

The Entrepreneurs have demonstrated commitment by participating as speakers at Endeavor events, and screening candidates.

From the Entrepreneurship Blog

Events

Three Keynote Speakers Announced for the 2015 Endeavor Entrepreneur Retreat

March 2nd, 2015 — by admin

The invite-only 2015 Endeavor Entrepreneur Retreat will take place May 6-8 in Westchester, NY. Three top-tier keynote speakers have been confirmed for the event: - Kenneth I. Chenault is Chairman a…

Read more

In the news

CNBC Features Endeavor Greece Research on Job Creation; Highlights the Need for Entrepreneurship

March 1st, 2015 — by admin

CNBC recently featured Endeavor Greece's Creating Jobs for Youth in Greece report, bringing focus to the need for  high-quality employment opportunities in the struggling economy.  The piece highlight…

Read more

Contact us

Press center

Community

Newsletter Sign Up